Mannitol Market Regional Analysis

Mannitol Market size was valued at USD 445.87 Million in 2023 and is poised to grow from USD 476.19 Million in 2024 to USD 806.02 Million by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The global mannitol market is highly competitive with the presence of several players. The market players are focusing on developing new applications of mannitol and expanding their product portfolio. Additionally, some players are investing in research and development activities to develop new applications of mannitol and improve its properties. 'Roquette', 'Cargill, Inc.', 'Ingredion Incorporated', 'SPI Pharma', 'Merck KGaA', 'Qingdao Bright Moon Seaweed Group Co. Ltd.', 'Zhejiang Huakang Pharmaceutical Co., Ltd.', 'Vizient, Inc.', 'Hebei Huaxu Pharmaceutical Co., Ltd.', 'EMD Millipore Corporation', 'Lianmeng Chemical Co., Ltd.', 'Shouguang Tiancheng Chemical Co., Ltd.', 'Pfanstiehl, Inc.', 'CarboMer, Inc.', 'Sigma-Aldrich Corporation', 'Perstorp Holding AB', 'Medtronic plc', 'Qingdao Free Trade Zone United International Co., Ltd.', 'Dancheng Caixin Sugar Industry Co., Ltd.', 'Alfa Aesar'

Mannitol is used as an active pharmaceutical ingredient (API) in several medications used to treat chronic diseases such as diabetes, heart disease, and cancer. The rising prevalence of these diseases worldwide is driving the demand for mannitol as a crucial component of these medications.

Increasing demand from the pharmaceutical industry: Mannitol is widely used as an excipient in the pharmaceutical industry to improve the solubility and bioavailability of drugs. With the growing prevalence of chronic diseases, the demand for drugs containing mannitol as an active ingredient or excipient is increasing, driving the growth of the mannitol market.

Asia Pacific led the global mannitol market, accounting for more than half of the overall market. Emerging markets like China and India accounted for a large share of the total market. Consumption in the regional market has increased as a result of rising consumer health consciousness. Diabetes is becoming more common in China as a result of the country's changing lifestyle and socioeconomic level, and this trend is expected to continue for the next eight years. However, two types of diabetes must be addressed immediately: obesity and cardiovascular disease. These factors are anticipated to increase market demand over the next eight years.